RACHELLE ROGERS: Open Payments
NPI 1154192516 · MARSHALL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Insulet Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: CAPLYTA, TZIELD, Omnipod, TEZSPIRE.
Industry payments across MO — which companies pay providers there.
